Taking people in United StatesNo phase
Observational Study of a New Inserter for the Travoprost Eye Implant
Checks a new implant inserter for travoprost in adults with glaucoma or high eye pressure.
Plain-language title generated from the registry record
Registry title: Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
Key facts
- Where
- Kenosha, United StatesSee the site
Where in United States
- KenoshaKenosha, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Glaukos Corporation
- Trial code
- NCT07400926
- Record updated
- 27 February 2026
- Original description
Clinical in-use observational trial to evaluate the updated inserter for the Travoprost Intracameral implant using the updated inserter (Model G2-TRIO)Read full original descriptionShow less
Clinical In-use Observational Trial to Evaluate the Updated Inserter for the Travoprost Intracameral Implant 75 mcg
Clinical in-use observational trial to evaluate the updated inserter for the Travoprost Intracameral implant using the updated inserter (Model G2-TRIO)
Inclusion: Diagnosis of Open-angle glaucoma; 18 years of age or older.
Exclusion: Subject who is breast-feeding or pregnant.